These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 14132744)

  • 21. [FAMILIAL INFANTILE HEMOCHROMATOSIS].
    JIMENEZDIAZ C; PERIANES J; PELAEZ JL; SANCHEZVILLARES E; LINAZASORO JM; VILLALOBOS E
    Rev Clin Esp; 1963 Oct; 91():11-7. PubMed ID: 14113318
    [No Abstract]   [Full Text] [Related]  

  • 22. [HEMOCHROMATOSIS].
    VERHAEGEN-DECLERCQ ML; VERHAEGEN H; DE GROOT EJ
    Belg Tijdschr Geneesk; 1964 Nov; 20():1165-74. PubMed ID: 14239616
    [No Abstract]   [Full Text] [Related]  

  • 23. [Specific treatment of excessive iron deposition in the tissues].
    Plachecka-Gutowska M; Mikolajew M
    Pol Arch Med Wewn; 1965; 35(1):111-7. PubMed ID: 5900073
    [No Abstract]   [Full Text] [Related]  

  • 24. [PRELIMINARY NOTE ON THE THERAPEUTIC USE OF DESFERRIOXAMINE IN COOLEY'S DISEASE].
    ROMANO C; MASSIMO L; TORTOROLO G
    Minerva Pediatr; 1964 Jun; 16():711-3. PubMed ID: 14180248
    [No Abstract]   [Full Text] [Related]  

  • 25. [INFLUENCE OF DESFERRIOXAMINE ON THE URINARY ELIMINATION OF IRON IN NORMAL AND PATHOLOGICAL SUBJECTS].
    MARCACCI M; CICALA P; GUIDONE M; NAPPI L; DIMARTINO G
    Clin Ter; 1964 Jan; 28():105-19. PubMed ID: 14122514
    [No Abstract]   [Full Text] [Related]  

  • 26. [Desferrioxamine-B in hemochromatosis].
    NORDOY A; BJORNSTAD P; HJORT PF
    Nord Med; 1963 May; 69():581-3. PubMed ID: 13938908
    [No Abstract]   [Full Text] [Related]  

  • 27. [Biologically active hydroxamic acids--iron complexons].
    Kol'tsova GN; Mel'nikovskaia NN; Likhodzievskiĭ KG; Rozenberg GIa
    Gematol Transfuziol; 1984 Sep; 29(9):56-9. PubMed ID: 6394425
    [No Abstract]   [Full Text] [Related]  

  • 28. Influence of desferrioxamine on the renal excretion of iron. Preliminary report.
    NIELSEN JB
    Acta Med Scand; 1963 Apr; 173():499-504. PubMed ID: 13938509
    [No Abstract]   [Full Text] [Related]  

  • 29. A CASE OF ACUTE IRON POISONING TREATED WITH DESFERRIOXAMINE B.
    SHAPIRO N; BARBEZAT GO
    S Afr Med J; 1964 Jul; 38():461-3. PubMed ID: 14179949
    [No Abstract]   [Full Text] [Related]  

  • 30. THE TREATMENT OF HAEMOCHROMATOSIS WITH DESFERRIOXAMINE.
    WOEHLER F
    Acta Haematol; 1963 Aug; 30():65-87. PubMed ID: 14064792
    [No Abstract]   [Full Text] [Related]  

  • 31. Iron overload disorders: natural history, pathogenesis, diagnosis, and therapy.
    McLaren GD; Muir WA; Kellermeyer RW
    Crit Rev Clin Lab Sci; 1983; 19(3):205-66. PubMed ID: 6373141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A NEW TEST FOR ASCERTAINMENT OF STATES OF SIDEROSIS: THE DESFERRIOXAMINE TEST. PRELIMINARY RESULTS].
    SCURO LA; BROCCIA G; DOBRILLA G; TAGLIAMONTE A
    Policlinico Prat; 1964 Jul; 71():1101-13. PubMed ID: 14174378
    [No Abstract]   [Full Text] [Related]  

  • 33. [TREATMENT OF HEMOCHROMATOSIS BY REPEATED BLEEDING AND DESFERROXAMINE].
    FOUET P; CONTE M; BODIN F
    Med Monde; 1964 Sep; 40():176-80. PubMed ID: 14231788
    [No Abstract]   [Full Text] [Related]  

  • 34. [The treatment of hemochromatosis with the new iron chelating agent (desferrioxamine)].
    CONTE M; BODIN F; DUHAMEL
    Bull Mem Soc Med Hop Paris; 1963 Apr 19-26; 114():533-8. PubMed ID: 14022705
    [No Abstract]   [Full Text] [Related]  

  • 35. [SIDERURIA INDUCED BY A NEW CHELATING AGENT: DESFERRIOXAMINE].
    WEILL JP; SCHIRARDIN H; ARBOGAST J; BERTHIER G
    Med Monde; 1964 Sep; 40():167-70. PubMed ID: 14224106
    [No Abstract]   [Full Text] [Related]  

  • 36. DETERMINATION OF DESFERRIOXAMINE-BOUND IRON IN URINE.
    KAHN LB
    S Afr Med J; 1964 Jul; 38():463-4. PubMed ID: 14179950
    [No Abstract]   [Full Text] [Related]  

  • 37. [Iron storage disorders].
    Strohmeyer G
    Haematol Blood Transfus; 1978; 21():163-70. PubMed ID: 367890
    [No Abstract]   [Full Text] [Related]  

  • 38. Hemochromatosis: course and treatment.
    Sherlock S
    Annu Rev Med; 1976; 27():143-9. PubMed ID: 180870
    [No Abstract]   [Full Text] [Related]  

  • 39. [Iron metabolism].
    Maspes VE; Barretto OC; Tamigaki M
    Rev Hosp Clin Fac Med Sao Paulo; 1987; 42(6):282-9. PubMed ID: 3455558
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hemosiderosis and idiopathic hemochromatosis].
    Nowotny P
    Z Gesamte Inn Med; 1967 Dec; 22(24):799-806. PubMed ID: 5585476
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.